Nu-Med Plus (NUMD) Assets Growth (5y) (2016 - 2025)
Nu-Med Plus (NUMD) Assets Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57.30% |
| Sep 30, 2025 | -62.15% |
| Jun 30, 2025 | -60.53% |
| Mar 31, 2025 | -35.74% |
| Dec 31, 2024 | -27.18% |
| Sep 30, 2024 | -39.39% |
| Jun 30, 2024 | -26.87% |
| Mar 31, 2024 | -43.35% |
| Dec 31, 2023 | -49.82% |
| Sep 30, 2023 | -52.23% |
| Jun 30, 2023 | -35.86% |
| Mar 31, 2023 | -28.90% |
| Dec 31, 2022 | -27.85% |
| Sep 30, 2022 | -63.04% |
| Jun 30, 2022 | -51.58% |
| Mar 31, 2022 | -53.11% |
| Dec 31, 2021 | -9.01% |
| Sep 30, 2021 | -27.33% |
| Jun 30, 2021 | -37.64% |
| Mar 31, 2021 | 17.51% |